FiercePharma1d
Journey Medical, with FDA nod, won't stop believing it can establish new rosacea standard of care
Dermatology drugmaker Journey Medical has trekked its Dr. Reddy’s Laboratories-partnered rosacea med across the FDA finish line as Emrosi. | The drug proved superiority in clearing lesions over ...
BioSpace2d
FDA Action Alert: Journey, Merus, PTC and Autolus
The FDA is set to decide on four promising therapies in the next two weeks, including a CAR T for acute lymphoblastic ...
Journey Medical announces presentation of DFD-29 data
Journey Medical (DERM) presented data assessing the dermal and systemic pharmacokinetics of oral DFD-29 versus oral Doxycycline 40 mg capsules ...
Theft of family van adds to the hardship of Sanger family's medical journey
Young car thieves are making life miserable and complicated for a Sanger family of six.The family spent hundreds of dollars ...
Medpage Today on MSN1d
Physician Explores Family's End-of-Life Journey in New Podcast
MedPage Today spoke with Ungerleider about her experience as a physician and medical journalist reporting on her own family's ...
The Punch Newspapers3d
Fareedah Badmus starts medical journey at Emory University
Recalling the experience, she told Society Plus, “I have been very cognisant of the stiff competition that comes with the ...
Impacts12d
The Surrogacy Process: Steps to Start Your Journey
Starting a family is a cherished dream for many, but not all can take the conventional path to parenthood. Surrogacy has ...
TravelPulse on MSN2d
Top Destinations for Medical Tourism and Proactive Wellness
From its rooftop pool to the cozy café serving health-conscious cuisine, this hotel complements your medical tourism ...
10 Leadership Lessons Learned From A Heartwarming Journey
The inspiring journey of a young boy provides more than just a heartwarming story; it offers a wealth of insights applicable ...
US FDA approves Journey Medical's drug for long-term skin condition
Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term ...
Business Insider1d
Journey Medical price target raised to $11 from $8.50 at Alliance Global Partners
Alliance Global Partners analyst Scott Henry raised the firm’s price target on Journey Medical (DERM) to $11 from $8.50 and reiterated a Buy rating on the shares. The firm noted the “underwhelmed” ...